2020 American Transplant Congress
Multi- National Survey among Nephrologists & Transplant Surgeons about the Suitability & Acceptance of the Marginal Living- Kidney Donors with Obesity or Abnormal Blood Sugar Profile
1KAMC, Riyadh, Saudi Arabia, 2Taif University, Taif, Saudi Arabia
*Purpose: There are no clear guidelines about the suitability and acceptance of living- kidney donors with obesity or abnormal blood sugar profile.*Methods: To form a…2020 American Transplant Congress
Efficacy and Safety Outcomes by Donor Type in De Novo Renal Transplant Recipients Receiving Everolimus with Reduced-Dose Calcineurin Inhibitor: 24-Month Results from Transform
1TRANSFORM Study Group, Basel, Switzerland, 2Novartis Pharma AG, Basel, Switzerland
*Purpose: To assess the efficacy and safety outcomes in de novo renal transplant (RTx) recipients receiving everolimus with reduced-exposure calcineurin inhibitor (EVR+rCNI) versus mycophenolate with…2020 American Transplant Congress
Multi- National Survey among Nephrologists & Transplant Surgeons About the Suitability and Acceptance of the Marginal Live Kidney Donors with Sickle Cell Trait
*Purpose: Due to organ shortage, many transplant centers may consider “marginal” kidney donors as those with sickle cell trait ( SCT) for donation. Acceptance of…2020 American Transplant Congress
Analysis of Factors Affecting Postoperative Hepatic Volume Increase in Liver Donor
Department of Surgery, Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: In living donor liver transplantation, donor safety is the top priority.Thus, the debate over how much a donor’s liver can be taken to recipient…2020 American Transplant Congress
Simultaneous Liver and Kidney Transplant Outcomes after “Safety Net” Policy Change
1University of Minnesota, Minneapolis, MN, 2Surgery, University of Minnesota, Minneapolis, MN
*Purpose: Criteria for listing for Simultaneous Liver and Kidney (SLK) transplant changed on August 10, 2017. These changes were implemented to standardize the criteria for…2020 American Transplant Congress
Multi- National Survey among Nephrologists & Transplant Surgeons about the Suitability and Acceptance of the Marginal Live Kidney Donors Regarding Urological Issues
*Purpose: Living donor kidney transplant is the primary modality of renal transplants in many countries. However, donors frequently present with some challenging conditions like some…2020 American Transplant Congress
Validation of the Graft Volume Formula Avoiding Small-for-Size Graft Dysfunction in Adult to Adult Living Donor Liver Transplantation
*Purpose: It is important to determine the optimal volume of liver graft in living donor liver transplantation(LDLT) for avoiding small-for-size graft syndrome(SFSS) A formula of…2020 American Transplant Congress
Depression Screening Protocol in Post Transplant Clinic. Implementing the A3 Scientific Method for Improving Patient Safety
Charles Strickler Transplant Center, University of Virginia Health System, Charlottesville, VA
*Purpose: Effect of the routine use of Patient Health Questionnaire PHQ-2 Screening in ambulatory transplant clinic to identify patients at risk for self-harm*Methods: Following a…2020 American Transplant Congress
Multi-National Survey among Nephrologists and Transplant Surgeons About the Suitability and Acceptance of the Marginal Live Kidney Donors Regarding Age Discrepancy
*Purpose: Living donor kidney transplantation is the best option for patients on dialysis. There are no guidelines or generally accepted consensus about the acceptable kidney…2020 American Transplant Congress
Left Lobe Living Donor Liver Transplantation Using Rapid Procedure in a Cirrhotic Patient with Hepatocellular Carcinoma with a GRWR of 0.35
*Purpose: Here, we describe a new approach using Rapid Procedure, a 2 stage hepatectomy technique, with living donor liver transplantation (LDLT) in the cirrhotic setting…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 19
- Next Page »